Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection

被引：12
|
作者：
Romani, Lorenza [1 ]
Carducci, Francesca Ippolita Calo [1 ]
Chiurchiu, Sara [1 ]
Cursi, Laura [1 ]
De Luca, Maia [1 ]
Di Giuseppe, Martina [1 ]
Krzysztofiak, Andrzej [1 ]
Lancella, Laura [1 ]
Palma, Paolo [2 ,3 ]
Vallesi, Leonardo [4 ]
Corsetti, Tiziana [4 ]
Campana, Andrea [5 ]
Nicastri, Emanuele [6 ]
Rossi, Paolo [3 ,7 ]
Bernardi, Stefania [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Immunol & Infect Dis Unit, IRCCS, I-00165 Rome, Italy
[2] Bambino Gesu Pediat Hosp, Res Unit Congenital & Perinatal Infect, IRCCS, I-00165 Rome, Italy
[3] Univ Roma Tor Vergata, Dept Syst Med, Chair Pediat, I-00133 Rome, Italy
[4] Bambino Gesu Pediat Hosp, Hosp Pharm Unit, IRCCS, I-00165 Rome, Italy
[5] Bambino Gesu Pediat Hosp, Dept Pediat, IRCCS, I-00165 Rome, Italy
[6] IRCCS, Natl Inst Infect Dis, I-00149 Rome, Italy
[7] Bambino Gesu Pediat Hosp, Acad Dept Pediat, IRCCS, I-00165 Rome, Italy
来源：
CHILDREN-BASEL | 2022年 / 9卷 / 03期
关键词：
COVID-19; monoclonal antibody; children;
D O I：
10.3390/children9030369
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Monoclonal antibody therapies for COVID-19 have been frequently used in adults, whereas there are little data regarding the safety or efficacy of monoclonal antibody treatments in pediatric patients affected by COVID-19. We report our experience in the administration of mAb as a treatment for SARS-CoV-2 infection in children aged from 24 days to 18 years old.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
    Wolfe, Ian D.
    Patel, Sameer J.
    CLINICAL THERAPEUTICS, 2021, 43 (06) : E157 - E162
  • [2] Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
    Kumar, Sonu
    Dutta, Debrupa
    Ravichandiran, Velayutham
    Sukla, Soumi
    3 BIOTECH, 2022, 12 (09)
  • [3] Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection
    Bruzzesi, Elena
    Ranzenigo, Martina
    Castagna, Antonella
    Spagnuolo, Vincenzo
    NEW MICROBIOLOGICA, 2021, 44 (03): : 135 - 144
  • [4] Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
    Sonu Kumar
    Debrupa Dutta
    Velayutham Ravichandiran
    Soumi Sukla
    3 Biotech, 2022, 12
  • [5] Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
    Guo, Youjia
    Kawaguchi, Atsushi
    Takeshita, Masaru
    Sekiya, Takeshi
    Hirohama, Mikako
    Yamashita, Akio
    Siomi, Haruhiko
    Murano, Kensaku
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [6] The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
    Xia, Yong
    Hong, Honghai
    Feng, Yao
    Liu, Meiling
    Pan, Xingfei
    Chen, Dexiong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 359 - 360
  • [7] SARS-CoV-2 Infection in Children
    Lu, Xiaoxia
    Zhang, Liqiong
    Du, Hui
    Zhang, Jingjing
    Li, Yuan Y.
    Qu, Jingyu
    Zhang, Wenxin
    Wang, Youjie
    Bao, Shuangshuang
    Li, Ying
    Wu, Chuansha
    Liu, Hongxiu
    Liu, Di
    Shao, Jianbo
    Peng, Xuehua
    Yang, Yonghong
    Liu, Zhisheng
    Xiang, Yun
    Zhang, Furong
    Silva, Rona M.
    Pinkerton, Kent E.
    Shen, Kunling
    Xiao, Han
    Xu, Shunqing
    Wong, Gary W. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (17): : 1663 - 1665
  • [8] SARS-CoV-2 infection in children
    Cokugras, Haluk
    Onal, Pinar
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2020, 55 (02): : 95 - 102
  • [9] Neutralizing antibodies for SARS-CoV-2 infection
    Berenguer, Juan
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 16 - 19
  • [10] Safety and Efficacy of Monoclonal Antibodies Against Sars-Cov-2 in a Heart Transplant Population
    Brink, H.
    Stoller, D.
    Lowes, B.
    Lundgren, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S193 - S193
12345